First Trust Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-20,857
| Closed | -$945K | – | 2501 |
|
|
2022
Q4 | $945K | Buy |
20,857
+14,302
| +218% | +$648K | ﹤0.01% | 1976 |
|
|
2022
Q3 | $458K | Buy |
+6,555
| New | +$458K | ﹤0.01% | 2233 |
|
|
2022
Q2 | – | Sell |
-4,335
| Closed | -$356K | – | 2642 |
|
|
2022
Q1 | $356K | Sell |
4,335
-46,405
| -91% | -$3.81M | ﹤0.01% | 2339 |
|
|
2021
Q4 | $7.44M | Buy |
+50,740
| New | +$7.44M | 0.01% | 1184 |
|
|
2021
Q3 | – | Sell |
-4,029
| Closed | -$651K | – | 2669 |
|
|
2021
Q2 | $651K | Sell |
4,029
-26,331
| -87% | -$4.25M | ﹤0.01% | 2190 |
|
|
2021
Q1 | $5.2M | Buy |
30,360
+13,332
| +78% | +$2.28M | 0.01% | 1216 |
|
|
2020
Q4 | $3.74M | Buy |
17,028
+8,429
| +98% | +$1.85M | 0.01% | 1244 |
|
|
2020
Q3 | $1.43M | Buy |
+8,599
| New | +$1.43M | ﹤0.01% | 1560 |
|
|
2020
Q2 | – | Sell |
-25,853
| Closed | -$1.99M | – | 2477 |
|
|
2020
Q1 | $1.99M | Buy |
+25,853
| New | +$1.99M | ﹤0.01% | 1271 |
|
|
2019
Q4 | – | Sell |
-25,535
| Closed | -$1.99M | – | 2477 |
|
|
2019
Q3 | $1.99M | Buy |
+25,535
| New | +$1.99M | ﹤0.01% | 1538 |
|